- Home
- BPTH vs BKYI Comparison
BPTH vs BKYI Comparison
Compare BPTH & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- BKYI
- Stock Information
- Founded
- BPTH 2007
- BKYI 1993
- Country
- BPTH United States
- BKYI United States
- Employees
- BPTH N/A
- BKYI N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- BKYI Computer Software: Prepackaged Software
- Sector
- BPTH Health Care
- BKYI Technology
- Exchange
- BPTH Nasdaq
- BKYI Nasdaq
- Market Cap
- BPTH 5.0M
- BKYI 3.2M
- IPO Year
- BPTH N/A
- BKYI 1997
- Fundamental
- Price
- BPTH $1.09
- BKYI $1.54
- Analyst Decision
- BPTH Strong Buy
- BKYI
- Analyst Count
- BPTH 2
- BKYI 0
- Target Price
- BPTH $30.00
- BKYI N/A
- AVG Volume (30 Days)
- BPTH 6.2M
- BKYI 637.0K
- Earning Date
- BPTH 11-15-2024
- BKYI 11-14-2024
- Dividend Yield
- BPTH N/A
- BKYI N/A
- EPS Growth
- BPTH N/A
- BKYI N/A
- EPS
- BPTH N/A
- BKYI N/A
- Revenue
- BPTH N/A
- BKYI $7,292,394.00
- Revenue This Year
- BPTH N/A
- BKYI $1.96
- Revenue Next Year
- BPTH N/A
- BKYI $9.65
- P/E Ratio
- BPTH N/A
- BKYI N/A
- Revenue Growth
- BPTH N/A
- BKYI N/A
- 52 Week Low
- BPTH $0.59
- BKYI $0.52
- 52 Week High
- BPTH $12.00
- BKYI $3.22
- Technical
- Relative Strength Index (RSI)
- BPTH 54.13
- BKYI 56.47
- Support Level
- BPTH $1.11
- BKYI $1.29
- Resistance Level
- BPTH $1.34
- BKYI $1.90
- Average True Range (ATR)
- BPTH 0.30
- BKYI 0.30
- MACD
- BPTH 0.02
- BKYI 0.06
- Stochastic Oscillator
- BPTH 16.36
- BKYI 37.70
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.